AI in Drug Discovery
Breakthroughs in AI are revolutionizing how we approach drug discovery, particularly in response to pandemics. By analyzing viral proteins and anticipating mutations, AI can help design long-lasting antibodies. The rapid approval of COVID drugs has prompted regulators to rethink clinical trial processes, paving the way for faster adaptations to new technologies in the future. Education and proactive discussions with regulators are essential to prepare for these advancements.In this clip
From this podcast
Practical AI
Learning the language of life
Related Questions